Vinall RL - Search Results

1

Profiling of gene expression changes caused by p53 gain-of-function mutant alleles in prostate cancer cells.

Tepper CG, Gregg JP, Shi XB, Vinall RL, Baron CA, Ryan PE, Desprez PY, Kung HJ, deVere White RW. Tepper CG, et al. Among authors: vinall rl. Prostate. 2005 Dec 1;65(4):375-89. doi: 10.1002/pros.20308. Prostate. 2005. PMID: 16037992

2

The R273H p53 mutation can facilitate the androgen-independent growth of LNCaP by a mechanism that involves H2 relaxin and its cognate receptor LGR7.

Vinall RL, Tepper CG, Shi XB, Xue LA, Gandour-Edwards R, de Vere White RW. Vinall RL, et al. Oncogene. 2006 Mar 30;25(14):2082-93. doi: 10.1038/sj.onc.1209246. Oncogene. 2006. PMID: 16434975

3

GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms.

Tepper CG, Vinall RL, Wee CB, Xue L, Shi XB, Burich R, Mack PC, de Vere White RW. Tepper CG, et al. Among authors: vinall rl. Prostate. 2007 Apr 1;67(5):521-35. doi: 10.1002/pros.20548. Prostate. 2007. PMID: 17252539

4

Inappropriate activation of androgen receptor by relaxin via beta-catenin pathway.

Liu S, Vinall RL, Tepper C, Shi XB, Xue LR, Ma AH, Wang LY, Fitzgerald LD, Wu Z, Gandour-Edwards R, deVere White RW, Kung HJ. Liu S, et al. Among authors: vinall rl. Oncogene. 2008 Jan 17;27(4):499-505. doi: 10.1038/sj.onc.1210671. Epub 2007 Jul 23. Oncogene. 2008. PMID: 17653089

5

Combination treatment of prostate cancer cell lines with bioactive soy isoflavones and perifosine causes increased growth arrest and/or apoptosis.

Vinall RL, Hwa K, Ghosh P, Pan CX, Lara PN Jr, de Vere White RW. Vinall RL, et al. Clin Cancer Res. 2007 Oct 15;13(20):6204-16. doi: 10.1158/1078-0432.CCR-07-0600. Clin Cancer Res. 2007. PMID: 17947488

6

Genistein combined polysaccharide enhances activity of docetaxel, bicalutamide and Src kinase inhibition in androgen-dependent and independent prostate cancer cell lines.

Burich RA, Holland WS, Vinall RL, Tepper C, White RW, Mack PC. Burich RA, et al. Among authors: vinall rl. BJU Int. 2008 Nov;102(10):1458-66. doi: 10.1111/j.1464-410X.2008.07826.x. Epub 2008 Jun 19. BJU Int. 2008. PMID: 18565171

7

Glycomic approach for potential biomarkers on prostate cancer: profiling of N-linked glycans in human sera and pRNS cell lines.

de Leoz ML, An HJ, Kronewitter S, Kim J, Beecroft S, Vinall R, Miyamoto S, de Vere White R, Lam KS, Lebrilla C. de Leoz ML, et al. Dis Markers. 2008;25(4-5):243-58. doi: 10.1155/2008/515318. Dis Markers. 2008. PMID: 19126968 Free PMC article.

8

MicroRNAs and their potential for translation in prostate cancer.

DeVere White RW, Vinall RL, Tepper CG, Shi XB. DeVere White RW, et al. Among authors: vinall rl. Urol Oncol. 2009 May-Jun;27(3):307-11. doi: 10.1016/j.urolonc.2009.01.004. Urol Oncol. 2009. PMID: 19414119 Free PMC article.

9

Nrdp1-mediated regulation of ErbB3 expression by the androgen receptor in androgen-dependent but not castrate-resistant prostate cancer cells.

Chen L, Siddiqui S, Bose S, Mooso B, Asuncion A, Bedolla RG, Vinall R, Tepper CG, Gandour-Edwards R, Shi X, Lu XH, Siddiqui J, Chinnaiyan AM, Mehra R, Devere White RW, Carraway KL 3rd, Ghosh PM. Chen L, et al. Cancer Res. 2010 Jul 15;70(14):5994-6003. doi: 10.1158/0008-5472.CAN-09-4440. Epub 2010 Jun 29. Cancer Res. 2010. PMID: 20587519 Free PMC article.

10

MiR-34a chemosensitizes bladder cancer cells to cisplatin treatment regardless of p53-Rb pathway status.

Vinall RL, Ripoll AZ, Wang S, Pan CX, deVere White RW. Vinall RL, et al. Int J Cancer. 2012 Jun 1;130(11):2526-38. doi: 10.1002/ijc.26256. Epub 2011 Dec 2. Int J Cancer. 2012. PMID: 21702042 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters